Your browser doesn't support javascript.
loading
Optimal Medical Therapy as First-Line Therapy for Chronic Coronary Syndromes: Lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA.
Brown, David L.
Affiliation
  • Brown DL; Department of Medicine (Cardiovascular Medicine), Washington University St. Louis School of Medicine, Campus Box 8086, 660 S. Euclid Avenue, St. Louis, MO, USA. dlb8366@gmail.com.
Cardiovasc Drugs Ther ; 36(5): 1039-1045, 2022 10.
Article de En | MEDLINE | ID: mdl-34767134
ABSTRACT
The chronic coronary syndromes (CCS) include patients with a classic history of angina pectoris in the presence of either risk factors for or known atherosclerotic coronary artery disease. Randomized, controlled trials conducted in the optimal medical therapy (OMT) era have convincingly demonstrated that adherence to the outdated paradigm focused on treatment of obstructive coronary disease with initial revascularization fails to reduce death or myocardial infarction and inconsistently reduces angina symptoms. Rather, OMT reduces events and improves symptoms and should be considered first-line treatment for patients with CCS.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie des artères coronaires / Courage / Infarctus du myocarde Type d'étude: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Cardiovasc Drugs Ther Sujet du journal: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie des artères coronaires / Courage / Infarctus du myocarde Type d'étude: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Cardiovasc Drugs Ther Sujet du journal: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique